AAAAAA
Results:
1-9
|
Results: 9
Authors:
Jocham, D
Durek, C
Citation: D. Jocham et C. Durek, Treatment of superficial tumors of the urinary bladder, UROLOGE A, 40(6), 2001, pp. 460-463
Authors:
Bohle, A
Durek, C
Citation: A. Bohle et C. Durek, The use of BCG in superficial carcinoma of the urinary bladder, UROLOGE A, 40(5), 2001, pp. 403-409
Authors:
Durek, C
Richter, E
Basteck, A
Rusch-Gerdes, S
Gerdes, J
Jocham, D
Bohle, A
Citation: C. Durek et al., The fate of bacillus Calmette-Guerin after intravesical instillation, J UROL, 165(5), 2001, pp. 1765-1768
Authors:
Frohn, C
Doehn, C
Durek, C
Bohle, A
Schlenke, P
Jocham, D
Kirchner, H
Citation: C. Frohn et al., Feasibility of the adoptive transfusion of allogenic human leukocyte antigen-matched natural killer cells in patients with renal cell carcinoma, J IMMUNOTH, 23(4), 2000, pp. 499-504
Authors:
Brandau, S
Suttmann, H
Riemensberger, J
Seitzer, U
Arnold, J
Durek, C
Jocham, D
Flad, HD
Bohle, A
Citation: S. Brandau et al., Perforin-mediated lysis of tumor cells by Mycobacterium bovis Bacillus Calmette-Guerin-activated killer cells, CLIN CANC R, 6(9), 2000, pp. 3729-3738
Authors:
Durek, C
Rusch-Gerdes, S
Jocham, D
Bohle, A
Citation: C. Durek et al., Sensitivity of BCG to modern antibiotics, EUR UROL, 37, 2000, pp. 21-25
Authors:
Jurczok, A
Gunther, J
Durek, C
Wulf, T
Brandau, S
Jocham, D
Bohle, A
Citation: A. Jurczok et al., Optimizing of the orthotopic murine bladder cancer model and its use in the evaluation for intravesical bacillus Calmette-Guerin immunotherapy, AKT UROL, 31(7), 2000, pp. 424-430
Authors:
Durek, C
Rusch-Gerdes, S
Jocham, D
Bohle, A
Citation: C. Durek et al., Interference of modern antibacterials with bacillus Calmette-Guerin viability, J UROL, 162(6), 1999, pp. 1959-1962
Authors:
Durek, C
Brandau, S
Ulmer, AJ
Flad, HD
Jocham, D
Bohle, A
Citation: C. Durek et al., Bacillus-Calmette-Guerin (BCG) and 3D tumors: An in vitro model for the study of adhesion and invasion, J UROL, 162(2), 1999, pp. 600-605
Risultati:
1-9
|